New drug duo aims to fight Tough-to-Treat prostate cancer
NCT ID NCT03787680
Summary
This study is testing whether a combination of two drugs, olaparib and AZD6738, can help control advanced prostate cancer that has spread and no longer responds to standard hormone treatments. It will involve about 49 men to see how well the drugs work together and how safe they are. The goal is to see if this combination can shrink tumors or lower PSA levels and delay the cancer's progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Hospital
Ann Arbor, Michigan, 48109, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
-
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.